Scroll to the end of the document to enable signing.
1. Purpose
To ensure electronic records and electronic signatures used at Quillbrook are trustworthy, reliable and equivalent to paper records and handwritten signatures, in accordance with 21 CFR Part 11.
2. Scope
Applies to all computerised systems used to create, modify, maintain, archive, retrieve or transmit records required by predicate rules, including electronic data capture, electronic source, the SOP acknowledgment system, the training system and email containing study records.
3. Responsibilities
- IT Director & HIPAA Security Officer: Maintains system inventory, validation records, access control and audit trail review.
- Quality Assurance Director: Approves validation documentation and periodically reviews electronic signature records.
- System Owners: Define user roles, request access changes, and confirm access reviews.
- All Users: Use only their own credentials, never share passwords, and understand that their electronic signature is legally binding.
4. Definitions
- Electronic record
- Any combination of text, graphics, data, audio or other information in digital form that is created, modified, maintained, archived, retrieved or distributed by a computer system.
- Electronic signature
- A computer data compilation of any symbol or series of symbols executed, adopted or authorised by an individual to be the legally binding equivalent of the individual's handwritten signature.
- Signature manifestation
- The displayed or printed information accompanying a signed record showing the printed name of the signer, the date and time, and the meaning of the signature.
- Audit trail
- Secure, computer-generated, time-stamped records that independently record the date, time and author of entries and changes, without obscuring previously recorded information.
5. Procedure
- Maintain an inventory of all computerised systems that hold records required by predicate rules, recording the system owner, validation status, and whether it holds protected health information.
- Validate each system before production use and after significant change, retaining requirements, test scripts, test evidence and a release approval.
- Assign every user a unique user identification; never create shared or generic accounts, and never permit one person to sign using another person's credentials.
- Apply role-based access with least privilege, and require a documented request from the system owner for every grant, change or revocation of access.
- Revoke access on the same business day that a person's employment ends or their role no longer requires the system, coordinating with HR & Admin and IT & Security.
- Enforce password complexity, expiry and lockout, and require automatic session logoff after a defined period of inactivity.
- Require a signature component check at the point of signing: the signer must confirm intent and re-enter credentials to execute an electronic signature.
- Include in every electronic signature record the printed name of the signer, the date and time of signing with the time zone offset, and the meaning associated with the signature such as read and understood, authored, reviewed or approved.
- Display the signature manifestation with the signed record and include it in any human-readable copy or printout of that record.
- Never allow an executed electronic signature or the record it applies to be altered or deleted; corrections are made by a new record that references the original, and a void action must record the reason, the actor and the time.
- Enable a secure, computer-generated, time-stamped audit trail in every system, retain it for at least as long as the underlying record, and make it available for review and copying.
- Review audit trails for critical records at a documented frequency, at minimum quarterly, and investigate anomalies through QA-002.
- Retain electronic records so they remain accurate, complete and readable throughout the retention period, and verify readability of archived records at least annually.
- Confirm that any external system or vendor holding regulated records provides Part 11 capability, an audit trail, and, where protected health information is involved, an executed business associate agreement per HIP-002.
- Certify to the FDA, where required, that electronic signatures used at the site are intended to be the legally binding equivalent of handwritten signatures.
6. References
- 21 CFR Part 11 — Electronic Records; Electronic Signatures
- FDA Guidance: Part 11, Electronic Records; Electronic Signatures — Scope and Application
- ICH E6(R3) Good Clinical Practice, computerised systems
- 45 CFR 164.312 — Technical safeguards
- DAT-001 Source Documentation & ALCOA+ Principles
7. Revision History
- v2.0 · Jul 11, 2023 — Added quarterly audit trail review.
- v3.0 · Feb 16, 2026 — Added signature manifestation and void-with-reason requirements for the SOP acknowledgment system.
— End of document —
Devan Ramaswamy
Read and understood · Jun 22, 2026, 09:57 AM UTC
Thaddeus Moreau, MD
Read and understood · Sep 23, 2026, 09:57 AM UTC
Priyanka Venkataraman, MD
Read and understood · Jul 08, 2026, 11:57 AM UTC
Cornelius Abara, MD
Read and understood · Sep 21, 2026, 11:57 AM UTC
Rosalind Achterberg, DO
Read and understood · Sep 18, 2026, 01:57 PM UTC
Silas Wentworth, PA-C
Read and understood · Sep 06, 2026, 08:57 AM UTC
Noor Al-Rashidi, NP
Read and understood · Sep 05, 2026, 02:57 PM UTC
Sunniva Lindqvist, RN
Read and understood · Sep 25, 2026, 10:57 AM UTC
Tomasz Wierzbicki
Read and understood · Jul 29, 2026, 08:57 AM UTC
Anaya Bhattacharya
Read and understood · Jun 30, 2026, 02:57 PM UTC
Lucinda Ferreira-Mota
Read and understood · Aug 24, 2026, 02:57 PM UTC
Adebayo Ogunleye
Read and understood · Jun 18, 2026, 01:57 PM UTC
Renzo Palacios, RN
Read and understood · Sep 05, 2026, 01:57 PM UTC
Ingeborg Strand, RN
Read and understood · Jun 21, 2026, 11:57 AM UTC
Delphine Rousseau
Read and understood · Aug 18, 2026, 09:57 AM UTC
Milo Ferrante
Read and understood · Sep 26, 2026, 03:57 PM UTC
Saoirse MacLochlainn, RN
Read and understood · Jun 30, 2026, 03:57 PM UTC
Jamal Whitfield
Read and understood · Jun 21, 2026, 03:57 PM UTC
Ximena Arredondo
Read and understood · Aug 30, 2026, 03:57 PM UTC
Ilse Vermeulen
Read and understood · Aug 31, 2026, 12:57 PM UTC
Sebastián Duarte
Read and understood · Jul 25, 2026, 09:57 AM UTC
Harriet Oyelaran
Read and understood · Jul 07, 2026, 08:57 AM UTC
Rosalie Beauchamp
Read and understood · Aug 15, 2026, 10:57 AM UTC
Tallulah Winthrop
Read and understood · Sep 28, 2026, 12:57 PM UTC
Solveig Aune, PharmD
Read and understood · Sep 20, 2026, 03:57 PM UTC
Rashida Karimova
Read and understood · Sep 01, 2026, 10:57 AM UTC
Desmond Achebe
Read and understood · Aug 04, 2026, 10:57 AM UTC
Ingrid Bäckström
Read and understood · Jul 14, 2026, 01:57 PM UTC
Casimir Olszewski
Read and understood · Jul 12, 2026, 02:57 PM UTC
Farrukh Tashkentov
Read and understood · Jun 27, 2026, 12:57 PM UTC
Coretta Blanchard
Read and understood · Jun 21, 2026, 02:57 PM UTC
Ravi Choudhury
Read and understood · Sep 15, 2026, 10:57 AM UTC
Malachi Osei-Tutu
Read and understood · Jul 19, 2026, 02:57 PM UTC
Adaeze Okafor
Read and understood · Aug 27, 2026, 10:57 AM UTC
Jasper Lindholm
Read and understood · Sep 27, 2026, 11:57 AM UTC
Ezekiel Barrantes
Read and understood · Jun 19, 2026, 12:57 PM UTC
Augustin Delacroix
Read and understood · Aug 27, 2026, 02:57 PM UTC
Miriam Sandoval-Reyes
Read and understood · Sep 28, 2026, 11:57 AM UTC